| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 214.15B | 229.21B | 216.92B | 194.03B | 172.10B | 173.57B |
| Gross Profit | 34.33B | 40.92B | 34.31B | 28.51B | 23.92B | 21.66B |
| EBITDA | 25.26B | 32.28B | 24.68B | 19.22B | 14.64B | 12.08B |
| Net Income | 13.83B | 18.06B | 13.19B | 10.04B | 7.17B | 5.22B |
Balance Sheet | ||||||
| Total Assets | 258.08B | 333.79B | 296.39B | 282.60B | 261.37B | 257.70B |
| Cash, Cash Equivalents and Short-Term Investments | 32.47B | 34.34B | 27.17B | 36.21B | 42.34B | 45.29B |
| Total Debt | 5.35B | 12.20B | 5.06B | 1.06B | 863.00M | 1.04B |
| Total Liabilities | 52.44B | 103.06B | 86.73B | 83.48B | 71.14B | 72.51B |
| Stockholders Equity | 191.99B | 215.75B | 195.72B | 185.79B | 177.23B | 172.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.67B | -9.12B | 3.76B | -93.00M | 6.80B |
| Operating Cash Flow | 0.00 | 10.52B | -4.34B | 7.38B | 13.23B | 9.51B |
| Investing Cash Flow | 0.00 | -4.70B | -5.77B | -4.18B | -12.44B | -6.64B |
| Financing Cash Flow | 0.00 | 1.94B | 169.00M | -7.93B | -2.34B | -2.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥307.44B | 15.97 | 7.43% | 2.78% | 2.69% | -6.83% | |
75 Outperform | ¥169.69B | 13.32 | ― | 2.81% | 12.49% | 26.17% | |
70 Outperform | ¥274.47B | 14.13 | ― | 2.79% | 5.66% | 38.22% | |
66 Neutral | ¥170.93B | 13.77 | ― | 2.72% | 12.72% | 17.23% | |
64 Neutral | ¥166.82B | 15.94 | ― | 2.87% | -1.92% | -12.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |